(XRAY) Shares Trading down at $58.51 (XRAY) Alert: Johnson Fistel…

0
45

DENTSPLY SIRONA Inc. (NASDAQ:XRAY):

(XRAY) Alert: Johnson Fistel Investigates DENTSPLY SIRONA Inc. Following Resignation of Top Three Officers and SEC Investigation; Encourages Investors to Contact the Firm.

The company is so far trading down by 0.80% percent from yesterday’s close.

Additionally DENTSPLY SIRONA Inc. announced a dividend for shareholders payable on Friday October 13th, 2017. The dividend will be $0.088 per share for the quarter or $0.35 annualized. The dividend yield will be $0.59. The ex-dividend date will be Thursday September 28th, 2017.

DENTSPLY SIRONA Inc., launched on February 15, 1983, is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. The Company operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. The Business’s principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, the Business’s consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ASTRA TECH, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, CERAMCO, CERCON, CEREC, CEREC MCX, CITANEST, DAC, DELTON, DENTSPLY, DETREY, DYRACT, ESTHET.X, GALILEOS, INLAB, IN-OVATION, INTEGO, LOFRIC, MAILLEFER, MIDWEST, MTM, NUPRO, OMNICAM, ORAQIX, ORIGO, ORTHOPHOS, OSSEOSPEED, PALODENT PLUS, PEPGEN P-15, PORTRAIT, PRIME & BOND, PROFILE, PROGLIDER, PROTAPER, RECIPROC, RINN, SANI-TIP, SCHICK, SENSE, SENTALLOY, SINIUS, SIROLASER, SIRONA, SLIMLINE, STYLUS, SULTAN, SUREFIL, T1, T2, T3, T4, TENEO, THERMAFIL, TRIODENT MATRIX SYSTEMS, TRUBYTE, VIPI, WAVEONE, WELLSPECT, XENO, XIVE, XYLOCAINE and ZHERMACK..

The stock last traded at $58.51 which is a tad above $57.21, the stock’s 50 day moving average and which is slightly below the 200 day moving average of $61.25. The 50 day moving average moved up $1.30 and the 200 day average went down $-2.74 or -4.48%.

In the last earnings report the EPS was $-3.43 and is estimated to be $2.68 for the current year with 229,501,000 shares now outstanding. Analysts expect next quarter’s EPS to be $0.88 with next year’s EPS anticipated to be $2.99.

Traders are a little more bearish on DENTSPLY SIRONA Inc. if you put credence in the change in short interest. The firm realized a rise in short interest from August 15, 2017 to August 31, 2017 of 27.13%. Short shares grew from 6,031,410 to 7,667,470 over that period. With short interest at 7,667,470 and short average daily volume at 1,836,641, days to cover is 4.0 and the percentage of shorted shares was 0.03% on August 31.

Several investment firms have released opinions on DENTSPLY SIRONA Inc. of late. On July 11, 2017 H.C. Wainwright starting coverage on the stock by announcing an initial rating of “Buy”. On August 10 Morgan Stanley made no change to the stock rating of “Overweight” but lowered the price target from $69.00 to $67.00.

August 23 investment analysts at Jefferies made no change to the company rating of “Buy” and lowered the price target to $66.00 from $70.00. October 6 investment analysts at Morgan Stanley maintained a company rating of “Overweight” but raised the price expectation to $69.00 from $67.00.